Watchlist Price Alert

Eton Pharmaceuticals Inc. (ETON)

NASDAQ: ETON · Real-Time Price · USD

20.24

0.00 (0.00%)

At close: May 22, 2025, 3:59 PM

20.78

2.66%

After-hours: May 22, 2025, 07:45 PM EDT

0.00% (1D)

Bid	19.97
Market Cap	542.79M
Revenue (ttm)	48.33M
Net Income (ttm)	-4.58M
EPS (ttm)	-0.18
PE Ratio (ttm)	-112.44
Forward PE	15.78
Analyst	Strong Buy

Ask	20.9
Volume	315,601
Avg. Volume (20D)	259,390
Open	20.40
Previous Close	20.24
Day's Range	19.63 - 20.60
52-Week Range	3.18 - 21.48
Beta	1.23

About ETON

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ETON

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ETON stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Eton Pharmaceuticals has released their quartely earnings on May 13, 2025:

Revenue of $17.28M exceeds estimates by $2.15M, with 116.95% YoY growth.

EPS of 0.07 exceeds estimates by 0.02, with n/a YoY .

Why Price Moved

1 week ago

+0.29%

ETON stock has given up its prior gain. Eton Pharm... Unlock content with Pro Subscription

1 week ago

+0.29%

Eton Pharmaceuticals shares are trading higher after the company reported better-than-expected Q1 financial results.

News

1 day ago · seekingalpha.com

Eton Pharmaceuticals Set To Dominate Orphan Drug Niche

Giant pharma companies are not the right owners of ultra-rare disease orphan drugs. The associated revenue streams are simply too small. ETON can acquire and develop these drugs, better serving patien...

1 week ago · seekingalpha.com

Eton Pharmaceuticals, Inc. (ETON) Q1 2025 Earnings Call Transcript

Eton Pharmaceuticals, Inc. (NASDAQ:ETON ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants David Krempa - Chief Business Officer Sean Brynjelsen - Chief Executive Officer ...

1 week ago · zacks.com

Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates

Eton Pharmaceuticals, Inc. (ETON) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to loss of $0.03 per share a year ago.

3 weeks ago · zacks.com

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release

Eton Pharmaceuticals (ETON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago · seekingalpha.com

Eton Pharmaceuticals, Inc. (ETON) Virtual Investor Day and Q4 2024 Earnings Call Transcript

Eton Pharmaceuticals, Inc. (NASDAQ:ETON ) Q4 2024 Earnings Conference Call March 18, 2025 10:00 AM ET Company Participants David Krempa - Chief Business Officer Sean Brynjelsen - Chief Executive Offic...

2 months ago · zacks.com

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates

Eton Pharmaceuticals, Inc. (ETON) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.09 per share a year ago.